Trevi Therapeutics, Inc. (TRVI) › Total LiabilitiesTrevi Therapeutics, Inc. (TRVI) — Total LiabilitiesAnnual figures by period end, from SEC filings.2020-12-31: $19.85M2021-12-31: $21.40M2022-12-31: $15.56M2023-12-31: $6.86M2024-12-31: $11.26M2025-12-31: $10.20M$10.20M2020-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$10.20M-9.4%2026-03-17Balance as of period end2024-12-31$11.26M+64.2%2026-03-17Balance as of period end2023-12-31$6.86M-55.9%2025-03-18Balance as of period end2022-12-31$15.56M-27.3%2024-03-20Balance as of period end2021-12-31$21.40M+7.8%2023-03-16Balance as of period end2020-12-31$19.85M—2022-03-17Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)